네뷸라이저 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Nebuliser Market size is expected to reach USD 2.64 Billion in 2034 from USD 1.43 Billion (2025) growing at a CAGR of 7.02% during 2026-2034.

The nebuliser market is expanding due to rising prevalence of respiratory conditions such as asthma, COPD, and chronic bronchitis. These devices convert liquid medication into mist for direct inhalation, offering fast and effective drug delivery. Increasing geriatric populations and heightened awareness of respiratory health are fueling adoption worldwide.

Technological innovation is driving the transition toward portable, battery-operated, and mesh nebulisers that offer improved efficiency and convenience. Integration with digital platforms allows for remote monitoring of inhalation patterns and treatment adherence. Manufacturers are also focusing on quieter, more compact designs that enhance patient compliance.

The market will benefit from expanding home healthcare infrastructure, rising pollution levels, and increasing prevalence of respiratory disorders in urban populations. Nebulisers are set to remain integral to respiratory therapeutics, combining ease of use, precision, and patient-centric innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Jet
• Mesh (Active, Passive)
• Ultrasonic

By Application

• COPD
• Cystic Fibrosis
• Asthma
• Others

By End-use

• Hospital And Clinics
• Emergency Centers
• Home Healthcare

COMPANIES PROFILED

• Omron Corporation, GE Healthcare, Koninklijke Philips NV, Vectura Group Plc, PARI Respiratory Equipment Inc, Aerogen, DeVilbiss Healthcare LLC, Beurer GmbH, Microlife Corporation, GF Health Products Inc, Rossmax International Ltd, BESCO MEDICAL LIMITED, Bremed Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEBULISER MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Jet Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Mesh (Active, Passive) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Ultrasonic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEBULISER MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. COPD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cystic Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEBULISER MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospital And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Emergency Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEBULISER MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEBULISER INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Omron Corporation
  • 9.2.2 GE Healthcare
  • 9.2.3 Koninklijke Philips N.V
  • 9.2.4 Vectura Group Plc
  • 9.2.5 PARI Respiratory Equipment Inc
  • 9.2.6 Aerogen
  • 9.2.7 DeVilbiss Healthcare LLC
  • 9.2.8 Beurer GmbH
  • 9.2.9 Microlife Corporation
  • 9.2.10 GF Health Products Inc
  • 9.2.11 Rossmax International Ltd
  • 9.2.12 BESCO MEDICAL LIMITED
  • 9.2.13 Bremed Ltd